Autopsy report · NCT00259714

Dialysate Sodium Individualization in Hemodialysis

“Protocol was not feasible - only 1 of 18 enrollees completed procedures.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 2 years 1 month before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Yale University

Sponsor type

University, hospital or other

Conditions

Hypertension; Hemodialysis Patients

Interventions

dialysate sodium individualization; standard dialysate sodium

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Craniofacial Applications of 3D Printing
  “There was lack of internal staff support and could not enroll participants.” (66% match in meaning)
• Efficacy of Rituximab in Acute Cellular Rejection in Renal Transplant Patients
  “The planned recruitment number of 180 Patient could not been achieved.” (65% match in meaning)
• Evaluation of Culture Negative Severe Acute Respiratory Infection in Mexico
  “Enrollment goal could not be met.” (64% match in meaning)
• Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function
  “It was not possible within the time frame to recruit the planned no. of patients.” (63% match in meaning)
• Hybrid Closed-Loop Insulin Delivery System in Type 1 Diabetes Candidates for a Living Donor Kidney Transplant
  “PI was unable to enroll anyone.” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.